RecruitingPhase 2NCT06308367
The Therapeutic Effect of Betaine in Syringomyelia
Studying Syringomyelia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Xuanwu Hospital, Beijing
- Intervention
- Betaine(drug)
- Enrollment
- 30 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2024 – 2028
Study locations (1)
- Fengzeng Jian, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06308367 on ClinicalTrials.govOther trials for Syringomyelia
Additional recruiting or active studies for the same condition.